Goal
The overall goal of this education is for participants to be able to recognize the role of renal denervation as a treatment for uncontrolled or resistant hypertension, discuss updated hypertension guidelines and current recommendations for renal denervation, and determine which patients with uncontrolled or resistant hypertension are best suited for renal denervation to incorporate the procedure into patient management care plans.

Learning Objectives

1. Discuss the latest guidelines for managing hypertension in relation to current recommendations for renal denervation as a treatment for resistant or uncontrolled hypertension.
2. Assess advanced hypertension management care plans and team-based care approaches for when to consider renal denervation treatment.
3. Analyze how renal denervation may impact management for patients with hypertension in various practice environments, including roles of the healthcare team, reimbursement, and procedural considerations.

Target Audience

• General cardiologists
• Hypertension specialists
• Advanced practice providers including nurse practitioners, physician associates and pharmacists

Ciantel Adair Blyler, PharmD, CHC
Cedars-Sinai Medical Center – Smidt Heart Institute
Hypertension & Vascular Biology Clinical Research Center
Los Angeles, CA USA
Dr. Blyler has disclosed that she has no actual or potential conflicts of interest in regard to this program.

Chris Owen, ACNP-BC, APRN, BSN, CRNP, MS, NP, RNFA, RN, AACC
Director Innovative Design & Simulation
American College of Cardiology
Washington, DC USA
Consultant Fees/Honoraria: Silkroad

Tiffany C. Randolph, MD, MHA, FACC
Director, Cone Health Heart and Vascular Center for Prevention
Director, Advanced Hypertension Clinic Director, Advanced Hypertension Clinic
Greensboro, NC USA
Consultant Fees/Honoraria: Medtronic
Speaker's Bureau: Edwards Lifesciences, ReCor Medical

Eugene Yang, MD, MS, FACC
Professor, Division of Cardiology
Carl and Renée Behnke Endowed Chair for Asian Health
University of Washington School of Medicine
Medical Director, Heart Institute, UW Medicine Eastside Specialty Center
Co-Director, UW Medicine Cardiovascular Wellness and Prevention Program
Seattle, Washington USA
Consultant Fees/Honoraria: Genentech Inc., Idorsia, Mineralys; QURE; Sky Labs
Research/Research Grants: Microsoft Research

Marwah Abdalla, MD, MPH, FACC
Associate Professor of Medicine
Co-Director Columbia Hypertension Center
Director of Cardiac Intensive Care Unit Education
Columbia University Irving Medical Center
New York, NY USA
Other: Resmed

Sumeet Brar, MD, MPH
Fellow in Cardiovascular Medicine
University of Washington
Seattle, WA USA
Dr. Brar has disclosed that he has no actual or potential conflicts of interest in regard to this program.

Stephanie Colello, MD
Interventional/Structural Cardiology Fellow
Hospital of the University of Pennsylvania
Philadelphia, PA USA
Dr. Colello has disclosed that she has no actual or potential conflicts of interest in regard to this program.

Jay Girl, MD, MPH
Associate Professor, Perelman School of Medicine
Chief, Interventional Cardiology
Hospital of the University of Pennsylvania
Philadelphia, PA USA
Consultant Fees/Honoraria: Abbott Laboratories, Boston Scientific, Inari Medical, Novartis Corporation
Research/Research Grants: Edwards, Inari Medical
Officer, Director, Trustee, or Other Fiduciary Role: PERT Consortium, SCAI

Tiffany C. Randolph, MD, MHA, FACC
Director, Cone Health Heart and Vascular Center for Prevention
Director, Advanced Hypertension Clinic Director, Advanced Hypertension Clinic
Greensboro, NC USA
Consultant Fees/Honoraria: Medtronic
Speaker's Bureau: Edwards Lifesciences, ReCor Medical

John P. Reilly, MD, FACC
Associate Professor of Clinical Medicine
Chief of Cardiology, Stony Brook Southampton Hospital
Director, East End Cardiology Development
Southampton, NY USA
Dr. Reilly has disclosed that he has no actual or potential conflicts of interest in regard to this program.

Husam Salah, MD
Cardiovascular Disease Fellow, Duke University Medical Center
Research Fellow, Duke Clinical Research Institute
Duke University
Durham, NC, USA
Consultant Fees/Honoraria: VisCardia

Eugene Yang, MD, MS, FACC
Professor, Division of Cardiology
Carl and Renée Behnke Endowed Chair for Asian Health
University of Washington School of Medicine
Medical Director, Heart Institute, UW Medicine Eastside Specialty Center
Co-Director, UW Medicine Cardiovascular Wellness and Prevention Program
Seattle, Washington USA
Consultant Fees/Honoraria: Genentech Inc., Idorsia, Mineralys, QURE, Sky Labs
Research/Research Grants: Microsoft Research

Registration is free. However, seats are limited so make sure to register for in-person participation today. The program starts with a complimentary lunch at noon.

If you are experiencing issues with registration, call Member Care at 800-253-4636 or 202-375-6000.

This course will be held at the Hilton New Orleans Riverside, Salon C and D.

The address is:
2 Poydras St.
New Orleans, LA 70130

The hotel is a 7-minute walk from the Ernest N. Morial Convention Center in New Orleans.

Credit Designation Statement:

The following types of credit are available for attending this in-person course:

• ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.

  Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

• Physicians: The ACCF designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• Nurses: The ACCF designates this educational activity for a maximum of 2.5 continuing nursing education contact hours. (Provider No. P0019).
• Physician Associates: The American College of Cardiology Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
• Pharmacists: ACCF designates this continuing education activity for 2.5 contact hours of the Accreditation Council for Pharmacy Education. ACPE Universal Activity Number (UAN): JA4008225-0000-26-004-L01-P
• Interprofessional Continuing Education (ICPE) Credit: This activity was planned by and for the healthcare team, and learners will receive 2.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

Joint Accreditation Statement:

In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Evaluation and Credit Claim:

Your feedback from this American College of Cardiology (ACC) educational course will help us to better target ACC educational initiatives and efforts to support you and your future learning needs.

In order to receive CME, ABIM MOC, CNE, CPE, AAPA, and/or IPCE credit, or a Certificate of Participation, you must complete the Evaluation & Credit Claim survey online. This survey link will be sent via email after the course.

We strongly recommend that the Evaluation and Credit Claim survey be submitted within one month of the course, but you must complete them within three months of the course.

Disclaimer Statement:
This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a clinician relative to diagnostic and treatment options for a specific patient's medical condition.

The American College of Cardiology Foundation (ACCF) does not warrant the completeness, accuracy or usefulness of any opinions, advice, services or other information provided through this activity. In no event will ACCF be liable for any decision made, or action taken, in reliance upon the information provided through this activity.

Accredited status does not imply endorsement by ACC of any commercial products displayed in conjunction with this activity.

ACCF reserves the right to modify faculty and program without notice.

Disclosure/Conflict of Interest Statement:
As a provider jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity, and scientific rigor in all of their directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors, in a position to control the content are required to disclose to the audience all relevant financial relationships he/she and/or his/her spouse or domestic partner may have, occurring within the past 24 months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investigational.

ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the education activity.

ACCF assesses conflicts of interest (COI) with its faculty, planners, managers, staff and other individuals who are in a position to control the content of certified activities. All relevant potential conflicts of interest that are identified are thoroughly vetted by course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup (ACWG) through a process that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations.

ACCF has taken the necessary steps to ensure that all relevant financial relationships have been mitigated.

Please note ACCF staff and the ACWG members involved with this activity have nothing to disclose, unless otherwise noted.